First Trust NYSE Arca Biotechnology Index Fund is an open-end management company. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the NYSE Arca Biotechnology Index (the Index). The Index is an equal dollar-weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. As of Dec 31 2013, the Fund's total assets were $983,610,857 and the Fund's investment portfolio was valued at $969,483,653. We show 1070 historical shares outstanding datapoints in our FDN shares outstanding history coverage, used to compute FDN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing FDN market cap history over the course of time is important for investors
interested in comparing FDN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of FDN versus a peer is one thing; comparing
FDN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like FDN can fluctuate over the course of history.
With this page we aim to empower investors researching FDN by allowing them to research the FDN market cap history. |
Free FDN Email Alerts:
Video: The Importance of Market Cap
